Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit

Autor: Panagiotis Moraitis, Christos Kattamis, Giorgos Chouliaras, Vassilios Ladis, Kirykos Zannikos, Vasilios Berdoukas, Eleni Berdoussi

Publikováno v: European Journal of Haematology. 85:335-344

Objectives: Cardiac complications because of transfusional iron overload are the main cause of death in thalassaemia major. New chelators and iron monitoring methods such as cardiac magnetic resonance (CMR) became available after the year 2000. We ev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8a830a3a0444041d3b1a50329f6f3099
https://doi.org/10.1111/j.1600-0609.2010.01491.x

The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study

Autor: Eleni Berdoussi, Giorgos Chouliaras, Vassilios Ladis, Panagiotis Moraitis, Kirykos Zannikos, Vasilios Berdoukas

Publikováno v: Journal of Cardiovascular Magnetic Resonance, Vol 11, Iss 1, p 20 (2009)
Journal of Cardiovascular Magnetic Resonance

Background Available iron chelation regimes in thalassaemia may achieve different changes in cardiac and hepatic iron as assessed by MR. The aim of this study was to assess the efficacy of four available iron chelator regimes in 232 thalassaemia majo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f671593b933c0c9a06c42afe0b2684
https://doi.org/10.1186/1532-429x-11-20

Reduction of Hepatic Iron in Patients with Thalassemia Major According to Iron Chelation Regime Assessed by MRI T2*

Autor: Vassilios Ladis, Panagiotis Moraitis, Kirikos Zannikos, Eleni Berdoussi, Vasilios Antonios Berdoukas, Giorgos Chouliaras

Publikováno v: Blood. 112:5410-5410

In 212 thalassemia major patients, repeated assessments for cardiac and hepatic iron (LIC) assessed by Magnetic Resonance Imaging (MRI – T2*) have been performed. The chelation regimes were either desferrioxamine (DFO), deferiprone (DFP), combinati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d710d8d963881b6f0cb4d2c44d612643
https://doi.org/10.1182/blood.v112.11.5410.5410